Maremmani, I.; Dematteis, M.; Gorzelanczyk, E.J.; Mugelli, A.; Walcher, S.; Torrens, M.
Long-Acting Buprenorphine Formulations as a New Strategy for the Treatment of Opioid Use Disorder. J. Clin. Med. 2023, 12, 5575.
https://doi.org/10.3390/jcm12175575
AMA Style
Maremmani I, Dematteis M, Gorzelanczyk EJ, Mugelli A, Walcher S, Torrens M.
Long-Acting Buprenorphine Formulations as a New Strategy for the Treatment of Opioid Use Disorder. Journal of Clinical Medicine. 2023; 12(17):5575.
https://doi.org/10.3390/jcm12175575
Chicago/Turabian Style
Maremmani, Icro, Maurice Dematteis, Edward J. Gorzelanczyk, Alessandro Mugelli, Stephan Walcher, and Marta Torrens.
2023. "Long-Acting Buprenorphine Formulations as a New Strategy for the Treatment of Opioid Use Disorder" Journal of Clinical Medicine 12, no. 17: 5575.
https://doi.org/10.3390/jcm12175575
APA Style
Maremmani, I., Dematteis, M., Gorzelanczyk, E. J., Mugelli, A., Walcher, S., & Torrens, M.
(2023). Long-Acting Buprenorphine Formulations as a New Strategy for the Treatment of Opioid Use Disorder. Journal of Clinical Medicine, 12(17), 5575.
https://doi.org/10.3390/jcm12175575